Mezigdomide (MEZI), Tazemetostat (TAZ), and Dexamethasone (DEX) in Patients (pts) with Relapsed/Refractory Multiple Myeloma (RRMM): Preliminary Results from the CA057-003 TrialLuciano Costa,Rakesh Popat,David Siegel,Fredrik Schjesvold,Saad Usmani,Nizar J. Bahlis,Albert Oriol,Michael Chu,Syed Abbas Ali,Karthik Ramasamy,Monique Hartley-Brown,Joaquin Martinez-Lopez,Allison Gaudy,Antonina Kurtova, Wen Zhang,Rafael Sarmiento, August Dietrich,Jessica Katz,Michael Pourdehnad,Paul RichardsonCLINICAL LYMPHOMA MYELOMA & LEUKEMIA（2024）引用 0|浏览0AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
